159 related articles for article (PubMed ID: 25457822)
1. QKI-5 suppresses cyclin D1 expression and proliferation of oral squamous cell carcinoma cells via MAPK signalling pathway.
Fu X; Feng Y
Int J Oral Maxillofac Surg; 2015 May; 44(5):562-7. PubMed ID: 25457822
[TBL] [Abstract][Full Text] [Related]
2. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
[TBL] [Abstract][Full Text] [Related]
3. Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma.
Liu G; Ren X; Gao C; Zhang W
Mol Med Rep; 2015 Aug; 12(2):2225-30. PubMed ID: 25872568
[TBL] [Abstract][Full Text] [Related]
4. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.
Kanazawa T; Iwashita T; Kommareddi P; Nair T; Misawa K; Misawa Y; Ueda Y; Tono T; Carey TE
Oncogene; 2007 Aug; 26(39):5762-71. PubMed ID: 17384686
[TBL] [Abstract][Full Text] [Related]
5. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression in oral squamous cell carcinoma and verrucous carcinoma: correlation with histological differentiation.
Angadi PV; Krishnapillai R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):e30-5. PubMed ID: 17197212
[TBL] [Abstract][Full Text] [Related]
7. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells.
Gan CP; Sam KK; Yee PS; Zainal NS; Lee BKB; Abdul Rahman ZA; Patel V; Tan AC; Zain RB; Cheong SC
Cell Oncol (Dordr); 2019 Aug; 42(4):477-490. PubMed ID: 30949979
[TBL] [Abstract][Full Text] [Related]
8. [Expression of activated ERK1/2 and cyclin D1 in oral squamous cell carcinoma].
Wang LH; Liu TJ; Geng L
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):854-5. PubMed ID: 17416010
[No Abstract] [Full Text] [Related]
9. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
[TBL] [Abstract][Full Text] [Related]
10. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
11. [Expression of tumor suppressor gene PTEN, PIP3 and cyclin D1 in oral squamous cell carcinoma and their correlations].
Xie SM; Shen LJ; Yin C; Ruan P; Yao X
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jul; 41(7):407-10. PubMed ID: 17067457
[TBL] [Abstract][Full Text] [Related]
12. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
13. Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma.
Jian CX; Yang MZ; Li P; Xiong J; Zhang ZJ; Li CJ; Chen A; Hu CM; Zhou JX; Li SH
Cancer Invest; 2012 Dec; 30(10):748-56. PubMed ID: 23088770
[TBL] [Abstract][Full Text] [Related]
14. The p38 MAPK pathway is critical for 5,5'-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells.
Choi KH; Kim HK; Kim JH; Choi ES; Shin JA; Lee SO; Chintharlapalli S; Safe S; Abdelrahim M; Kong G; Choi HS; Jung JY; Cho HT; Cho NP; Cho SD
Eur J Cancer Prev; 2010 Mar; 19(2):153-9. PubMed ID: 19949342
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
Gao QZ; Lu JJ; Liu ZD; Zhang H; Wang SM; Xu H
Asian J Androl; 2008 Jul; 10(4):635-41. PubMed ID: 18097517
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity.
Zhou X; Zhang Z; Yang X; Chen W; Zhang P
Int J Cancer; 2009 Jan; 124(2):483-9. PubMed ID: 18942709
[TBL] [Abstract][Full Text] [Related]
17. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
19. Effects of activated fibroblasts on phenotype modulation, EGFR signalling and cell cycle regulation in OSCC cells.
Berndt A; Büttner R; Gühne S; Gleinig A; Richter P; Chen Y; Franz M; Liebmann C
Exp Cell Res; 2014 Apr; 322(2):402-14. PubMed ID: 24394543
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-27b inhibits cell proliferation in oral squamous cell carcinoma by targeting FZD7 and Wnt signaling pathway.
Liu B; Chen W; Cao G; Dong Z; Xu J; Luo T; Zhang S
Arch Oral Biol; 2017 Nov; 83():92-96. PubMed ID: 28735227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
